Stay updated on Dara-Pembro Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Dara-Pembro Combo in Myeloma: Clinical Trial page.

Latest updates to the Dara-Pembro Combo in Myeloma: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history shows a new revision entry: Revision: v3.3.3, and a removal of the HHS Vulnerability Disclosure footer link, along with deletion of Revision: v3.3.2. These are routine site maintenance notes and do not affect trial information displayed on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe Study Record Versions now show Revision: v3.3.2 and remove Revision: v3.2.0 on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the banner about a lapse in government funding, which previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check61 days agoChange DetectedThe latest version updates the Study Status and Recruitment Status sections within the study record history.SummaryDifference0.1%

- Check90 days agoChange DetectedCore content now includes an important government-operating-status notice and the site version is updated to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

- Check97 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Dara-Pembro Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Pembro Combo in Myeloma: Clinical Trial page.